Trial Profile
Multiple-dose Tolerability and Pharmacokinetic Studies of Benapenem for Injection in Phase Ib Clinical Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Feb 2019
Price :
$35
*
At a glance
- Drugs Benapenem (Primary)
- Indications Urinary tract infections
- Focus First in man; Pharmacokinetics
- Sponsors Sihuan Pharmaceutical Holdings Group
- 07 Jan 2019 Results of Part A, B, C (NCT03588156, NCT03578588, NCT03570970) published in the Antimicrobial Agents and Chemotherapy.
- 04 Jul 2018 New trial record